BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15626488)

  • 1. Can CD3+/HLA-DR+ activated T cells predict the prognosis of non-Hodgkin's lymphoma patients?
    Váróczy L; Gergely L; Miltényi Z; Aleksza M; Illés A
    Immunol Lett; 2005 Feb; 97(1):155-7. PubMed ID: 15626488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
    Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
    Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
    Trieb K; Lechleitner T; Lang S; Windhager R; Kotz R; Dirnhofer S
    Pathol Res Pract; 1998; 194(10):679-84. PubMed ID: 9820863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral leukocytes with HLA-DR+/CD8- phenotype are associated with prognosis in patients with lung cancer.
    Nakamura H; Saji H; Aute I; Kawasaki N; Hosaka M; Ogata A; Saijo T; Kato H
    Anticancer Res; 2003; 23(5b):4149-52. PubMed ID: 14666616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin's lymphoma and multiple myeloma.
    Vela-Ojeda J; García-Ruiz Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Mayani H; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR
    Ann Hematol; 2006 May; 85(5):308-14. PubMed ID: 16525786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
    Czyz A; Kołacz E; Angerer D; Zawilska K
    Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of antigen-presenting cells in human apical periodontitis lesions by flow cytometry and immunocytochemistry.
    Lukić A; Vasilijić S; Majstorović I; Vucević D; Mojsilović S; Gazivoda D; Danilović V; Petrović R; Colić M
    Int Endod J; 2006 Aug; 39(8):626-36. PubMed ID: 16872457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
    Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
    Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
    Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analyses of subset, activated state and expression pattern of 24 repertoire TCR Vbeta of peripheral blood T lymphocytes in convalescence patients with severe acute respiratory syndrome (SARS)].
    Zeng X; Cai C; Huang Y; Ou AH; Zhang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):114-7. PubMed ID: 15629099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased transendothelial migration of scleroderma lymphocytes.
    Stummvoll GH; Aringer M; Grisar J; Steiner CW; Smolen JS; Knobler R; Graninger WB
    Ann Rheum Dis; 2004 May; 63(5):569-74. PubMed ID: 15082489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
    Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation of peripheral blood lymphoid cells in children in remission a year after the cessation of treatment for acute lymphoblastic leukemia and non-Hodgkin's lymphoma type non-B].
    Wylezoł I; Mazur B; Sońta-Jakimczyk D; Olejnik I
    Wiad Lek; 1998; 51 Suppl 4():140-4. PubMed ID: 10731958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.
    Andersson R; Hansson GK; Söderström T; Jonsson R; Bengtsson BA; Nordborg E
    Clin Exp Immunol; 1988 Jul; 73(1):82-7. PubMed ID: 3048814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 and CD8 distribution profile in individuals infected by Schistosoma mansoni.
    Oliveira-Prado R; Caldas IR; Teixeira-Carvalho A; Andrade MV; Gazzinelli A; Correa-Oliveira R; Cunha-Melo JR
    Scand J Immunol; 2009 Jun; 69(6):521-8. PubMed ID: 19439013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated T lymphocytes in pre-eclampsia.
    Darmochwal-Kolarz D; Saito S; Rolinski J; Tabarkiewicz J; Kolarz B; Leszczynska-Gorzelak B; Oleszczuk J
    Am J Reprod Immunol; 2007 Jul; 58(1):39-45. PubMed ID: 17565546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children.
    Luczyński W; Stasiak-Barmuta A; Krawczuk-Rybak M; Malinowska I
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):357-63. PubMed ID: 16088321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease.
    Baker C; Chang L; Elsegood KA; Bishop AJ; Gannon DH; Narendran P; Leech NJ; Dayan CM
    Clin Exp Immunol; 2007 Mar; 147(3):472-82. PubMed ID: 17302896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.